Photocure ASA: Results for the third quarter of 2023 : vimar

/PRNewswire/ -- Photocure ASA (OSE:PHO) today reported Hexvix®/Cysview® revenues of NOK 107.3 million in the third quarter of 2023 (Q3 2022: NOK 96.9 million),...

Related Keywords

China , Oslo , Norway , Norwegian , Erik Dahl , Karl Storz , Hexvix Cysview , Dan Schneider , David Moskowitz , Tolv Hillestad , Prnewswire Photocure , Corporate Communications Norway , Oslo Stock Exchange , Stryker Corporation , Bladder Cancer Company , Chief Executive Officer , Blue Light Cystoscopy , Abuse Regulation , Norwegian Securities Trading , Group Controller , Photocure ,